Supplementary Table from Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication

Hiroto Inaba,Jolieke G. van Oosterwijk,John C. Panetta,Lie Li,Daelynn R. Buelow,James S. Blachly,Sheila Shurtleff,Ching‐Hon Pui,Raul C. Ribeiro, Jeffrey E. Rubnitz,Stanley Pounds,Sharyn D. Baker

openalex（2023）

引用 0|浏览8

暂无评分

摘要

Supplementary Table from Preclinical and Pilot Study of Type I FLT3 Tyrosine Kinase Inhibitor, Crenolanib, with Sorafenib in Acute Myeloid Leukemia and FLT3-Internal Tandem Duplication

查看译文

关键词

flt3 tyrosine kinase inhibitor,acute myeloid leukemia,sorafenib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要